Optimizing Therapy for Patients with Acute and Chronic Graft-Versus-Host Disease (GvHD)

Moderator Michael Bishop, MD leads a discussion with panelists Hannah Choe, MD, Doris M. Ponce, MD, and Bart L Scott, MD, concerning recent updates in the prevention, diagnosis, and treatment of Graft-Versus-Host Disease.

EP. 1: Understanding Chronic and Acute Graft-Versus-Host Disease Presentation and Diagnosis

June 23rd 2023

Moderator Michael Bishop, MD introduces expert panelists and leads an overview of Graft-Versus-Host Disease, covering the differences between chronic and acute conditions, how GvHD is typically diagnosed, and GvHD risk assessment.

EP. 2: Improving Patient Outcomes: Prophylactic Options in Graft-Versus-Host Disease

June 23rd 2023

Panelists Hannah Choe, MD, and Bart L Scott, MD share insights concerning prophylaxis in Graft-Versus-Host Disease, including key study data and current standards of care as well as discuss the potential role of biomarkers in GvHD.

EP. 3: Optimal First-Line Treatment Approaches for Acute GvHD

July 14th 2023

Subject-matter experts delve into the diagnosis, risk assessment, and treatment selection process for acute GvHD, emphasizing differentiation of refractory disease.

EP. 4: Treatment Options in Steroid-Refractory Acute GvHD

July 14th 2023

Treatment options for steroid refractory acute GvHD, including ruxolitinib efficacy and NCCN guideline adherence, take center stage in the discussion.

EP. 5: Enhancing Patient Care in Acute GvHD: Supportive Measures

July 21st 2023

Supportive care measures for acute GvHD are explored, highlighting strategies to manage symptoms and improve patient well-being.

EP. 6: Advancements and Promising Directions in Acute GvHD

July 21st 2023

Experienced clinicians discuss the future of acute GvHD treatment, focusing on gaps in patient care and potential therapy options.

EP. 7: Establishing Treatment Objectives for Chronic GvHD: First-Line Strategies

July 28th 2023

Insights on treatment strategies and goals for initial chronic GvHD management, including treatment selection rationale and dosing.

EP. 8: A Comprehensive Look at Initial Treatment Options for Chronic GvHD

July 28th 2023

Exploring FDA-approved treatment options for patients with chronic GvHD, with a focus on trial data and adverse effects.

EP. 9: Data-Driven Treatment Selection for Patients with Chronic GvHD

August 4th 2023

Clinical pearls for community oncologists regarding treatment selection and sequencing in chronic GvHD patients.

EP. 10: Remote Patient Monitoring and Supportive Care Measures in Chronic GvHD

August 4th 2023

Addressing patient monitoring in chronic GvHD, including therapy adjustment indicators and frequency.

EP. 11: The Future of Chronic GvHD Treatment

August 11th 2023

Expert panelists share final thoughts concerning the future of chronic GvHD treatment, highlighting unmet needs, ongoing trials, and promising therapies.